Skip to main content
Clinical Trials/CTRI/2018/05/013640
CTRI/2018/05/013640Not yet recruitingPhase 2

An open clinical evaluation on Uthiravadha suronitham(Rheumatoid arthritis) with siddha trial drug Rajaloga naatharasa parpam(Int),Paruthi thylam (Ext) and ottradam (Therapy)

Government Siddha Medical College0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Low grade fever
  • 2.Morning stiffness >1hours
  • 3.Arthritis of >=3 joint area of the possible 28
  • 4.Arthritis of hand joints[MCPs , PIPs ,
  • 5.Symmetric swelling â??same joints on both sides
  • 6.Redness of joints
  • 7.Rheumatoid nodules
  • 8.Serum rheumatoid factor[RA factor]+ve or -ve
  • 9.Anti ccp +ve

Exclusion Criteria

  • 1.Systemic lupus erythematosis
  • 2.Sub acute bacterial endocarditis
  • 3.Rheumatic fever
  • 4.Gouty arthritis
  • 5.Carries spine
  • 6.Ankylosing spondylitis
  • 7.Psoriatic arthritis
  • 8.Osteomyelitis
  • 9.Renal failure
  • 10.Tumours
  • 11.History of long term intake of steroid
  • 13.Progressive systemic sclerosis
  • 14.Pregnancy&lactation
  • 15.Chickungunya

Investigators

Sponsor
Government Siddha Medical College

Similar Trials